Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Intravenous Sodium Bicarbonate in Treating Patients With Severe Metabolic Acidemia.

Kraut JA, Madias NE.

Am J Kidney Dis. 2018 Oct 18. pii: S0272-6386(18)30914-4. doi: 10.1053/j.ajkd.2018.08.011. [Epub ahead of print] No abstract available.

PMID:
30343957
2.

Secondary Response to Chronic Respiratory Acidosis in Humans: A Prospective Study.

González SB, Menga G, Raimondi GA, Tighiouart H, Adrogué HJ, Madias NE.

Kidney Int Rep. 2018 Jun 8;3(5):1163-1170. doi: 10.1016/j.ekir.2018.06.001. eCollection 2018 Sep.

3.

Re-Evaluation of Total CO2 Concentration in Apparently Healthy Younger Adults.

Kraut JA, Lew V, Madias NE.

Am J Nephrol. 2018;48(1):15-20. doi: 10.1159/000489965. Epub 2018 Jul 10.

PMID:
29990967
4.

Sodium bicarbonate for severe metabolic acidaemia.

Kraut JA, Madias NE.

Lancet. 2018 Jul 7;392(10141):3-4. doi: 10.1016/S0140-6736(18)31305-9. Epub 2018 Jun 14. No abstract available.

PMID:
29910039
5.

Re-Evaluation of the Normal Range of Serum Total CO2 Concentration.

Kraut JA, Madias NE.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):343-347. doi: 10.2215/CJN.11941017. Epub 2018 Jan 16.

PMID:
29339355
6.

Retarding progression of chronic kidney disease: use of modalities that counter acid retention.

Kraut JA, Madias NE.

Curr Opin Nephrol Hypertens. 2018 Mar;27(2):94-101. doi: 10.1097/MNH.0000000000000386. Review.

PMID:
29140821
7.

Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease.

Kraut JA, Madias NE.

Adv Chronic Kidney Dis. 2017 Sep;24(5):289-297. doi: 10.1053/j.ackd.2017.06.005. Review.

PMID:
29031355
8.

Hospital-Associated Hypernatremia Spectrum and Clinical Outcomes in an Unselected Cohort.

Tsipotis E, Price LL, Jaber BL, Madias NE.

Am J Med. 2018 Jan;131(1):72-82.e1. doi: 10.1016/j.amjmed.2017.08.011. Epub 2017 Aug 30.

PMID:
28860033
9.

Nonosmotic Na+ storage and the Edelman equation.

Adrogué HJ, Madias NE.

Kidney Int. 2017 Aug;92(2):514. doi: 10.1016/j.kint.2017.03.050. No abstract available.

PMID:
28709601
10.

In Reply to 'Sodium-Chloride Difference as a Simple Parameter for Acid-Base Status Assessment'.

Adrogué HJ, Madias NE.

Am J Kidney Dis. 2017 May;69(5):708. doi: 10.1053/j.ajkd.2017.01.039. Epub 2017 Mar 9. No abstract available.

PMID:
28285872
11.

Sodium and potassium in the pathogenesis of hypertension: focus on the brain.

Adrogué HJ, Madias NE.

Curr Opin Nephrol Hypertens. 2017 Mar;26(2):106-113. doi: 10.1097/MNH.0000000000000301. Review.

PMID:
27906749
12.

Assessing Acid-Base Status: Physiologic Versus Physicochemical Approach.

Adrogué HJ, Madias NE.

Am J Kidney Dis. 2016 Nov;68(5):793-802. doi: 10.1053/j.ajkd.2016.04.023. Epub 2016 Aug 31.

PMID:
27590096
13.

Lactic Acidosis: Current Treatments and Future Directions.

Kraut JA, Madias NE.

Am J Kidney Dis. 2016 Sep;68(3):473-82. doi: 10.1053/j.ajkd.2016.04.020. Epub 2016 Jun 10.

PMID:
27291485
14.

Metabolic Acidosis of CKD: An Update.

Kraut JA, Madias NE.

Am J Kidney Dis. 2016 Feb;67(2):307-17. doi: 10.1053/j.ajkd.2015.08.028. Epub 2015 Oct 23. Review.

PMID:
26477665
15.

Atypical case of AL amyloidosis with urinary erythrocyte casts.

Liangos O, Buettner-Herold M, Ketteler M, Madias NE.

Clin Nephrol Case Stud. 2015 Sep 23;3:19-24. doi: 10.5414/CNCS108640. eCollection 2015.

16.

Lactic acidosis.

Kraut JA, Madias NE.

N Engl J Med. 2015 Mar 12;372(11):1078-9. doi: 10.1056/NEJMc1500327. No abstract available.

17.

Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis.

Sewaralthahab K, Rennke H, Sewaralthahab S, Madias NE, Jaber BL.

Clin Nephrol Case Stud. 2014 Dec 15;3:31-36. doi: 10.5414/CNCS108420. eCollection 2015.

18.

Lactic acidosis.

Kraut JA, Madias NE.

N Engl J Med. 2014 Dec 11;371(24):2309-19. doi: 10.1056/NEJMra1309483. Review. No abstract available.

19.

Hospital-acquired acute kidney injury and hospital readmission: a cohort study.

Koulouridis I, Price LL, Madias NE, Jaber BL.

Am J Kidney Dis. 2015 Feb;65(2):275-82. doi: 10.1053/j.ajkd.2014.08.024. Epub 2014 Oct 22.

PMID:
25446018
20.

The impact of sodium and potassium on hypertension risk.

Adrogué HJ, Madias NE.

Semin Nephrol. 2014 May;34(3):257-72. doi: 10.1016/j.semnephrol.2014.04.003. Epub 2014 Apr 18. Review.

PMID:
25016398
21.

Diagnosis and treatment of hyponatremia.

Adrogué HJ, Madias NE.

Am J Kidney Dis. 2014 Nov;64(5):681-4. doi: 10.1053/j.ajkd.2014.06.001. Epub 2014 Jul 2. No abstract available.

PMID:
24996937
22.

Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension.

Adrogué HJ, Madias NE.

J Am Soc Hypertens. 2014 Mar;8(3):203-13. doi: 10.1016/j.jash.2013.09.003. Epub 2013 Nov 5. Review.

PMID:
24200471
23.

Association of serum bicarbonate with clinical outcomes in CKD: could an increase in serum bicarbonate be a double-edged sword?

Kraut JA, Madias NE.

Am J Kidney Dis. 2013 Oct;62(4):647-9. doi: 10.1053/j.ajkd.2013.07.001. No abstract available.

PMID:
24054938
24.

Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Koulouridis I, Alfayez M, Tighiouart H, Madias NE, Kent DM, Paulus JK, Jaber BL.

Am J Kidney Dis. 2013 Oct;62(4):730-7. doi: 10.1053/j.ajkd.2013.02.373. Epub 2013 May 10.

25.

Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure.

Shchekochikhin DY, Schrier RW, Lindenfeld J, Price LL, Jaber BL, Madias NE.

Circ Heart Fail. 2013 May;6(3):379-86. doi: 10.1161/CIRCHEARTFAILURE.112.000106. Epub 2013 Mar 19.

PMID:
23512983
26.

Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.

Susantitaphong P, Sewaralthahab K, Balk EM, Eiam-ong S, Madias NE, Jaber BL.

Am J Hypertens. 2013 Mar;26(3):424-41. doi: 10.1093/ajh/hps038. Epub 2013 Jan 7.

27.

Treatment of acute metabolic acidosis: a pathophysiologic approach.

Kraut JA, Madias NE.

Nat Rev Nephrol. 2012 Oct;8(10):589-601. doi: 10.1038/nrneph.2012.186. Epub 2012 Sep 4. Review.

PMID:
22945490
28.

Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review.

Susantitaphong P, Sewaralthahab K, Balk EM, Jaber BL, Madias NE.

Am J Nephrol. 2012;35(6):540-7. doi: 10.1159/000339329. Epub 2012 May 29. Review.

29.

The challenge of hyponatremia.

Adrogué HJ, Madias NE.

J Am Soc Nephrol. 2012 Jul;23(7):1140-8. doi: 10.1681/ASN.2012020128. Epub 2012 May 24. Review.

30.

Differential diagnosis of nongap metabolic acidosis: value of a systematic approach.

Kraut JA, Madias NE.

Clin J Am Soc Nephrol. 2012 Apr;7(4):671-9. doi: 10.2215/CJN.09450911. Epub 2012 Mar 8. Review.

31.

Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.

Susantitaphong P, Koulouridis I, Balk EM, Madias NE, Jaber BL.

Am J Kidney Dis. 2012 May;59(5):689-99. doi: 10.1053/j.ajkd.2011.12.020. Epub 2012 Feb 25.

32.

Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.

Sarafidis PA, Georgianos PI, Germanidis G, Giavroglou C, Nikolaidis P, Lasaridis AN, Madias NE.

Am J Kidney Dis. 2012 Mar;59(3):434-8. doi: 10.1053/j.ajkd.2011.11.001. Epub 2011 Dec 9.

PMID:
22154539
33.

Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.

Jaber BL, Almarzouqi L, Borgi L, Seabra VF, Balk EM, Madias NE.

Am J Med. 2011 Oct;124(10):977.e1-9. doi: 10.1016/j.amjmed.2011.04.028.

34.

Renal acidification responses to respiratory acid-base disorders.

Madias NE.

J Nephrol. 2010 Nov-Dec;23 Suppl 16:S85-91. Review.

PMID:
21170892
35.

Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Kraut JA, Madias NE.

Pediatr Nephrol. 2011 Jan;26(1):19-28. doi: 10.1007/s00467-010-1564-4. Epub 2010 Jun 5. Review.

36.

Secondary responses to altered acid-base status: the rules of engagement.

Adrogué HJ, Madias NE.

J Am Soc Nephrol. 2010 Jun;21(6):920-3. doi: 10.1681/ASN.2009121211. Epub 2010 Apr 29.

37.

The role of the renin-angiotensin system in the regulation of erythropoiesis.

Vlahakos DV, Marathias KP, Madias NE.

Am J Kidney Dis. 2010 Sep;56(3):558-65. doi: 10.1053/j.ajkd.2009.12.042. Epub 2010 Apr 18. Review.

PMID:
20400218
38.

Metabolic acidosis: pathophysiology, diagnosis and management.

Kraut JA, Madias NE.

Nat Rev Nephrol. 2010 May;6(5):274-85. doi: 10.1038/nrneph.2010.33. Epub 2010 Mar 23. Review.

PMID:
20308999
39.

Impact of hospital-associated hyponatremia on selected outcomes.

Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE.

Arch Intern Med. 2010 Feb 8;170(3):294-302. doi: 10.1001/archinternmed.2009.513.

PMID:
20142578
40.

Assessing acid-base disorders.

Adrogué HJ, Gennari FJ, Galla JH, Madias NE.

Kidney Int. 2009 Dec;76(12):1239-47. doi: 10.1038/ki.2009.359. Epub 2009 Oct 7. Review.

41.

A 56-year-old man in the intensive care unit with a complex acid-base disturbance.

Madias NE.

Am J Kidney Dis. 2009 Sep;54(3):561-6. doi: 10.1053/j.ajkd.2009.06.008. No abstract available.

PMID:
19700062
42.

Shared primacy of sodium and potassium on cardiovascular risk.

Adrogué HJ, Madias NE.

Am J Kidney Dis. 2009 Oct;54(4):598-601. doi: 10.1053/j.ajkd.2009.05.008. Epub 2009 Jul 4. No abstract available.

PMID:
19577349
43.

Epidemiology of hyponatremia.

Upadhyay A, Jaber BL, Madias NE.

Semin Nephrol. 2009 May;29(3):227-38. doi: 10.1016/j.semnephrol.2009.03.004. Review.

PMID:
19523571
44.

A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury.

Kolyada AY, Tighiouart H, Perianayagam MC, Liangos O, Madias NE, Jaber BL.

Kidney Int. 2009 Jun;75(12):1322-1329. doi: 10.1038/ki.2009.68. Epub 2009 Mar 11.

45.

Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury.

Kolyada AY, Liangos O, Madias NE, Jaber BL.

Am J Nephrol. 2008;28(2):203-9. Epub 2007 Oct 24.

PMID:
17960058
46.

Serum anion gap: its uses and limitations in clinical medicine.

Kraut JA, Madias NE.

Clin J Am Soc Nephrol. 2007 Jan;2(1):162-74. Epub 2006 Dec 6. Review.

47.

Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia.

Madias NE.

Am J Kidney Dis. 2007 Aug;50(2):184-7. Review. No abstract available.

PMID:
17660019
48.

Sodium and potassium in the pathogenesis of hypertension.

Adrogué HJ, Madias NE.

N Engl J Med. 2007 May 10;356(19):1966-78. Review. No abstract available.

PMID:
17494929
49.

Uric acid homeostasis in the evaluation of diuretic-induced hyponatremia.

Liamis G, Christidis D, Alexandridis G, Bairaktari E, Madias NE, Elisaf M.

J Investig Med. 2007 Jan;55(1):36-44.

PMID:
17441410
50.

A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation.

Sosa MA, Balk EM, Lau J, Liangos O, Balakrishnan VS, Madias NE, Pereira BJ, Jaber BL.

Nephrol Dial Transplant. 2006 Oct;21(10):2825-33. Epub 2006 Jul 22. Review.

PMID:
16861726

Supplemental Content

Loading ...
Support Center